Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Operating Income (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Operating Income for 16 consecutive years, with -$6.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Income fell 8.86% to -$6.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$25.5 million, a 4.28% decrease, with the full-year FY2024 number at -$25.1 million, up 5.98% from a year prior.
  • Operating Income was -$6.4 million for Q3 2025 at GeoVax Labs, down from -$5.4 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$1.5 million in Q2 2021 to a low of -$13.7 million in Q4 2021.
  • A 5-year average of -$5.4 million and a median of -$5.4 million in 2025 define the central range for Operating Income.
  • Peak YoY movement for Operating Income: crashed 927.89% in 2021, then surged 60.8% in 2022.
  • GeoVax Labs' Operating Income stood at -$13.7 million in 2021, then soared by 60.8% to -$5.4 million in 2022, then plummeted by 42.81% to -$7.7 million in 2023, then dropped by 8.46% to -$8.3 million in 2024, then grew by 23.62% to -$6.4 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Operating Income are -$6.4 million (Q3 2025), -$5.4 million (Q2 2025), and -$5.4 million (Q1 2025).